Entrada Therapeutics, Inc.TRDANASDAQ
Loading
Other Income/Expenses (Net) Over TimeContracting
Percentile Rank67
3Y CAGR+71.0%
5Y CAGR+146.8%
Year-over-Year Change
Net other income and expenses outside core operations
3Y CAGR
+71.0%/yr
Annual compound
5Y CAGR
+146.8%/yr
Recent deceleration
Percentile
P67
Within normal range
vs 5Y Ago
91.5x
Strong expansion
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $13.17M | -32.4% |
| 2024 | $19.47M | +28.0% |
| 2023 | $15.22M | +478.2% |
| 2022 | $2.63M | +8590.3% |
| 2021 | $-31000.00 | -121.5% |
| 2020 | $144000.00 | -97.9% |
| 2019 | $6.72M | - |